Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2370 of 6351
-
New study aims to improve diagnosis of stomach tumors
Diagnosis Recruiting nowGastrointestinal stromal tumors (GISTs) are the most common submucosal tumors (SMTs) of the stomach. The 2022 European Society of Oncology ESMO Diagnosis and Treatment Guidelines recommend that GISTs undergo biopsy with a clear pathological diagnosis and should be removed unless …
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Ancient needle therapy takes on chronic bladder pain
Symptom relief CompletedInterstitial cystitis/bladder pain syndrome is a non-bacterial chronic inflammatory disease of the bladder characterized by lower urinary tract symptoms such as dysuria, irritating urgency, and nocturia, as well as pelvic pain associated with bladder filling. The International C…
Sponsor: Medipol University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New pill could ease Post-Surgery pain without opioids
Symptom relief CompletedMR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after bunionectomy.
Phase 3 • Sponsor: Viatris Specialty LLC • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New urine test could spot bladder cancer early in remote greenland
Diagnosis CompletedThe goal of this observational study is to evaluate whether a urinary biomarker (Xpert® Bladder Cancer Detection Test) can be used as a selection tool to decide which patients that should undergo cystoscopy in haematuria work-up or in other indications where bladder tumor is susp…
Sponsor: Jørgen Bjerggaard Jensen • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Diabetes drug trial halted: could BMF-219 have boosted insulin?
Disease control CompletedPhase 2 Trial of BMF-219 in Participants with Type 1 Diabetes Mellitus.
Phase 2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug cocktail aims to improve kidney transplant success
Disease control CompletedThe purpose of this study is to evaluate the safety and efficacy of TCD601 in combination with Belatacept when compared to standard of care immunosuppression therapy in de novo renal transplant patients.
Phase 2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could 2 days of antibiotics be enough for deadly Flesh-Eating infections?
Disease control Recruiting nowNecrotizing soft tissue infection (NSTI) is a devastating disease that results in a high rate of in-hospital complications and despite advances in critical care, wound care, and early intervention, NSTI continues to be associated with a mortality rate of nearly 30%. The antibioti…
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New strategy aims to keep breast cancer patients on Full-Dose targeted therapy
Disease control Recruiting nowThis is a post-marketing single arm, phase IV trial in which patients with high-risk early-stage HR+HER2- breast cancer will receive adjuvant abemaciclib in combination with endocrine therapy (ET) After study intervention, participants will remain on combination abemaciclib + ET …
Phase 4 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could leg vein disease weaken breathing and strength?
Knowledge-focused CompletedIn the literature, it is still unclear whether individuals with chronic venous insufficiency are affected by edema, pain, respiratory muscle strength, respiratory functions, functional capacity, lower extremity strength and quality of life compared to asymptomatic healthy individ…
Sponsor: Izmir Democracy University • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
New breathalyzer aims to sniff out COVID-19 in seconds
Diagnosis Recruiting nowThe primary objective of this effort will be to optimize and operationalize innovative passive surveillance systems and in parallel, the effort will identify, evaluate, and transition groundbreaking new technologies in diagnostics for operationalization. To meet the objective an…
Sponsor: The Geneva Foundation • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
New scan could sharpen targeting of breast cancer brain spread
Diagnosis Recruiting nowThe goal of this interventional study is to optimize the protocol of FES PET/CT in Estrogen Receptor positive Breast cancer patients with Brain metastases. Patients will undergo MRI of the brain and FDG PET/CT brain as part of standard of care for radiation treatment planning. An…
Phase 4 • Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Exercise program aims to help anxious smokers kick the habit
Symptom relief Recruiting nowAnxiety sensitivity, reflecting the fear of bodily sensations, is a risk factor for the maintenance and relapse of smoking. This study is designed to address the question - is a smoking cessation intervention personalized to high anxiety sensitive smokers and adapted for implemen…
Phase 3 • Sponsor: Jasper A. Smits • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Italian study tracks new antibody drugs for lymphoma patients
Knowledge-focused Recruiting nowThis is a prospective, observational cohort study to evaluate the clinical impact of novel Monoclonal AntiBodies (MAB) in B-cell Non-Hodgkin Lymphoma (NHL) in Italian clinical practice.
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New painkiller aims to ease suffering after abdominal surgery
Symptom relief CompletedPrimary Objective: To explore the analgesic efficacy of YZJ-4729 compared with placebo in patients with acute postoperative pain following abdominal surgery. Secondary Objective: To explore the analgesic efficacy and safety of YZJ-4729 compared with placebo and morphine in patie…
Phase 2 • Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
10,000 pregnant women join study to uncover virus risks
Knowledge-focused Recruiting nowThis study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during week 6-13 of pregnancy at Government Medical College Hospital, Nagpur. The Hospital provides primary, secondary, and terti…
Sponsor: Boston University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Triple-Drug cocktail for septic shock shows promise in small trial
Disease control CompletedThe goal of this prospective randomized controlled trial is to compare the effects of classic stepwise vs. early balanced multimodal vasopressor strategies in septic shock.
Phase 2/3 • Sponsor: University Medical Centre Maribor • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can lupus patients safely get the shingles vaccine? new trial aims to find out
Disease control Recruiting nowThis randomized, double-blind, placebo-controlled, non-inferiority crossover study will evaluate the Herpes Zoster Sunbit (HZ/su) vaccine in SLE patients in order to evaluate safety and immunogenicity in patients with variable baseline clinical activities, ages and immunosuppress…
Phase 4 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New depression pill shows promise in Late-Stage trial
Symptom relief CompletedThis randomized, double-blind, placebo-controlled, multicenter study will evaluate the effects of NMRA-335140 (formerly BTRX-335140) on symptoms of depression in participants with Major Depressive Disorder (MDD). The study design consists of a Screening Period (up to 35 days), an…
Phase 3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Pill power: oral antibiotic could replace IV for tough UTIs
Disease control CompletedThe primary purpose of this study is to assess the efficacy of oral TBP-PI-HBr as compared with intravenous (IV) imipenem-cilastatin with respect to the overall response (combined clinical cure plus microbiological eradication) at the Test-of-Cure (TOC) visit in hospitalized adul…
Phase 3 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New ointment could treat larger patches of Sun-Damaged skin
Disease control CompletedThe purpose of the study is to evaluate the efficacy and safety of tirbanibulin 10 milligrams per gram (mg/g) ointment when applied to a treatment field (TF) larger than 25 square centimeters (cm\^2) and up to 100 cm\^2 in adult participants with actinic keratosis (AK).
Phase 3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC